(S (NP (NP (NN Response)) (PP (IN of) (NP (NN breast) (NN cancer))) (S (VP (TO to) (VP (VB neoadjuvant) (NP (NN chemotherapy))))) (PRN (-LRB- -LRB-) (NP (NN NAC)) (-RRB- -RRB-))) (VP (MD can) (VP (VB be) (VP (VBN monitored) (S (VP (VBG using) (NP (DT the) (NN change)) (PP (IN in) (NP (NP (JJ visible) (NN tumor)) (PP (IN on) (NP (NML (JJ magnetic) (NN resonance)) (NN imaging))))))) (PRN (-LRB- -LRB-) (NP (NN MRI)) (-RRB- -RRB-))))) (. .))
(S (PP (IN In) (NP (PRP$ our) (JJ current) (NN workflow))) (, ,) (NP (NN seed) (NNS points)) (VP (VBP are) (ADVP (RB manually)) (VP (VBN placed) (PP (IN in) (NP (NP (NNS areas)) (PP (IN of) (NP (NN enhancement))))) (S (ADJP (JJ likely) (S (VP (TO to) (VP (VB contain) (NP (NN cancer))))))))) (. .))
(S (NP (NP (DT A) (ADJP (JJ constrained)) (NN volume)) (VP (VBG growing) (NP (NN method)))) (VP (VP (VBZ uses) (NP (NP (DT these) (ADJP (RB manually) (VBN placed)) (NN seed) (NNS points)) (PP (IN as) (NP (NN input))))) (CC and) (VP (VBZ generates) (NP (DT a) (NN tumor) (NN segmentation)))) (. .))
(S (NP (DT This) (NN method)) (VP (VBZ is) (ADVP (RB rigorously)) (VP (VBN validated) (S (VP (VBG using) (NP (JJ complete) (JJ pathological) (NN embedding)))))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBP propose) (S (VP (TO to) (VP (VB exploit) (NP (NP (JJ deep) (NN learning)) (PP (IN for) (NP (ADJP (JJ fast) (CC and) (JJ automatic)) (NN seed) (NN point) (NN detection)))) (, ,) (S (VP (VBG replacing) (NP (NP (JJ manual) (NN seed) (NN point) (NN placement)) (PP (IN in) (NP (PRP$ our) (ADJP (ADJP (VBG existing)) (CC and) (ADJP (RB well) (HYPH -) (VBN validated))) (NN workflow)))))))))) (. .))
(S (NP (DT The) (NML (NN seed) (NN point)) (NN generator)) (VP (VBD was) (VP (VBN developed) (PP (IN in) (NP (JJ early) (NML (NN breast) (NN cancer)) (NNS patients))) (PP (IN with) (NP (NP (NP (ADJP (NP (NN pathology)) (HYPH -) (VBN proven)) (NNS segmentations)) (-LRB- -LRB-) (S (NP (NN N)) (VP (SYM =) (NP (CD 100)))) (-RRB- -RRB-)) (, ,) (VP (VBN operated) (ADVP (RB shortly)) (PP (IN after) (NP (NN MRI)))))))) (. .))
(S (NP (PRP It)) (VP (VBD consisted) (PP (IN of) (NP (NP (DT an) (NN ensemble)) (PP (IN of) (NP (NP (CD three) (ADJP (RB independently) (VBN trained)) (ADJP (RB fully) (JJ convolutional) (JJ dilated)) (JJ neural) (NNS networks)) (SBAR (WHNP (WDT that)) (S (VP (VBD classified) (NP (NN breast) (NNS voxels)) (PP (IN as) (NP (NN tumor) (CC or) (NN non-tumor))))))))))) (. .))
(S (ADVP (RB Subsequently)) (, ,) (NP (JJ local) (NNS maxima)) (VP (VBD were) (VP (VBN used) (PP (IN as) (NP (NN seed) (NNS points))) (PP (IN for) (NP (NP (NN volume)) (VP (VBG growing) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN NAC)))))))) (PRN (-LRB- -LRB-) (S (NP (NN N)) (VP (SYM =) (NP (CD 10)))) (-RRB- -RRB-)))) (. .))
(S (NP (NP (DT The) (NN percentage)) (PP (IN of) (NP (NML (NN tumor) (NN volume)) (NN change)))) (VP (VBD was) (VP (VBN evaluated) (PP (IN against) (NP (JJ semi-automatic) (NNS segmentations))))) (. .))
(S (NP (DT The) (JJ primary) (NN cancer)) (VP (VBD was) (VP (VBN localized) (PP (IN in) (NP (NP (CD 95) (NN %)) (PP (IN of) (NP (DT the) (NNS tumors))))) (PP (IN at) (NP (NP (DT the) (NN cost)) (PP (IN of) (NP (NP (NP (CD 0.9)) (ADJP (JJ false) (JJ positive))) (PP (IN per) (NP (NN patient))))))))) (. .))
(S (NP (JJ False) (NNS positives)) (VP (VBD included) (ADVP (RB focally) (S (VP (VBG enhancing) (NP (NP (NP (NNS regions)) (PP (IN of) (NP (JJ unknown) (NN origin)))) (CC and) (NP (NP (NNS parts)) (PP (IN of) (NP (DT the) (JJ intramammary) (NN blood) (NNS vessels))))))))) (. .))
(S (NP (NP (NN Volume)) (VP (VBG growing) (PP (IN from) (NP (DT the) (NN seed) (NNS points))))) (VP (VBD showed) (NP (NP (DT a) (JJ median) (NML (NN tumor) (NN volume)) (NN decrease)) (PP (IN of) (NP (CD 70) (NN %))) (PRN (-LRB- -LRB-) (FRAG (NP (JJ interquartile) (NN range)) (: :) (NP (QP (CD 50) (NN %) (HYPH -) (CD 77) (NN %)))) (-RRB- -RRB-))) (, ,) (S (ADJP (JJ comparable) (PP (IN to) (NP (DT the) (JJ semi-automatic) (NNS segmentations))))) (PRN (-LRB- -LRB-) (NP (NN median)) (: :) (NP (NP (CD 70) (NN %)) (, ,) (NP (NP (JJ interquartile) (NN range)) (NP (QP (CD 23) (NN %) (HYPH -) (CD 76) (NN %))))) (-RRB- -RRB-))) (. .))
(S (S (VP (TO To) (VP (VB conclude)))) (, ,) (NP (DT a) (ADJP (JJ fast) (CC and) (JJ automatic)) (NN seed) (NN point) (NN generator)) (VP (VBD was) (VP (VBN developed) (, ,) (S (ADVP (RB fully)) (VP (VBG automating) (NP (NP (DT a) (ADJP (RB well) (HYPH -) (VBN validated)) (JJ semi-automatic) (NN workflow)) (PP (IN for) (NP (NP (NN response) (NN monitoring)) (PP (IN of) (NP (NN breast) (NN cancer))))) (S (VP (TO to) (VP (VB neoadjuvant) (NP (NN chemotherapy)))))))))) (. .))
